 <p><strong>Investing in Cures Before Missiles Act of 2021 or the ICBM Act</strong></p> <p>This bill addresses the transfer and use of funds intended for defense programs. Specifically, the bill requires the Department of Defense (DOD) to transfer $1 billion of unobligated balances intended for its ground-based strategic deterrent program to the National Institute of Allergy and Infectious Disease for research on the development of a universal coronavirus vaccine.</p> <p>Next, the bill requires the Department of Energy to transfer unobligated balances for the W87-1 warhead modification program administered by the National Nuclear Security Administration to the Centers for Disease Control and Prevention to research and combat emerging and zoonotic infectious diseases.</p> <p>The bill prohibits the use of funds authorized for FY2022 for the ground-based strategic deterrent program or the W87-1 warhead modification program.</p> <p>Finally, the bill requires DOD to enter into a contract with the National Academy of Sciences to study extending to 2050 the life of Minuteman III intercontinental ballistic missiles.</p>